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Introduction 
The global aid architecture has undergone a significant transformation with the emergence of 
new donors and the growing role of the private sector within development assistance. In the 
health sector there has been a proliferation of global public private partnerships (GPPPs1) that 
bring together actors from the public and private sector and are frequently oriented toward a 
specific disease or group of diseases. Among the most prominent GPPPs are the Global Fund to 
fight AIDS, Tuberculosis and Malaria (GFATM) and the Global Alliance for Vaccines and 
Immunization (GAVI).  
 
The interaction between the public and private sector is not new in itself, but changing ideology 
in the international development landscape has facilitated the growth of public-private 
partnerships (PPPs), embedding a new type of relationship. PPPs bring together players from 
both the public and private sectors, including state and global level organizations, private 
                                                 
1 Global Public-Private Partnerships (GPPPs) in Health are also described as Global Health Initiatives (GHIs), 
Global Health Partnerships (GHPs) or Public-Private Interactions (PPIs). This paper will refer to them as PPPs, 
unless quoting a specific study which refers to them by one of the other acronyms.  
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foundations, and trans-national corporations. A useful definition is offered by Buse and Harmer 
(2007) who describe GPPPs as:  
 
Relatively institutionalised initiatives, established to address global health problems, 
in which public and for-profit private sector organizations have a voice in collective 
decision-making. Such partnerships vary across a range of variables including their 
functional aims, the size of their secretariats and budgets, their governing 
arrangements, and their performance. Yet it is their innovative approach to joint 
decision-making among multiple partners from the public and private sectors which 
make them a unique unit of analysis ... (2007: 259-60).  
 
In practice these ‘partnerships’ can take a number of different forms, with ‘partners’ providing a 
whole range of activities from funding, to education, to joint research activities. Hawkes and 
Buse (2011: 400) suggest that an important distinction is between partnerships where decision-
making powers are shared among partners and those PPPs which are merely characterised by 
‘participation’ from both the public and private sector.  
 
A growing body of research has explored the history and diverse composition of PPPs (Buse and 
Walt, 2000; Buse and Tanaka, 2011; Hanefeld et al, 2007) with particular attention given to the 
governance-related challenges of PPPs and their unintended health system effects (Buse et al. 
2009; Ruckert and Labonté, 2014). However, as Kapilashrami and McPake (2013) argue less 
attention has been given to the ideas underpinning these partnerships and the practices they 
generate. At the same time, discussion has focused on global level PPPs with very little attention 
given to smaller scale, national level PPPs. Taking this as a point of departure and drawing on 
research conducted with UK-based NGOs, this paper will argue that insufficient attention has 
been given to how these partnerships impact on development policy and practice. Specifically, 
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the paper will argue that the majority of the discussion of PPPs in health has been gender blind 
and fails to consider that not only are PPPs gendered institutions but they also have gendered 
impacts on development practice in health. Focusing on women’s health programming within 
UK-based NGOs, the paper argues that PPPs have institutionalized and legitimized an 
instrumental discourse of women’s health in development practice. The paper will argue that this 
is problematic because it serves to curtail the potential overall gains and fails to uphold wider 
government and international level commitments to women’s rights.  
 
Defining Women’s Health  
Women’s health can be understood as involving their emotional, social, cultural, and physical 
well being, and is determined by the social, political, cultural and economic context of women’s 
lives, as well as by biology. This definition recognizes the validity of women’s life experiences, 
and women’s own beliefs about, and experiences of, health (Inhorn 2006). However, in order to 
help make the distinction between a purely instrumental approach to women’s health, and a 
broader approach based on transformative gains, the paper draws on the distinction between a 
gender equity and gender equality approach. Gender equity applies the general concept of equity 
in provision of health services to men and women, asking for example whether health systems 
respond equally to men and women in equal need (Standing 1997). Such approaches attempt to 
address gender inequalities in health status by strengthening services to women and promoting 
greater participation of women at all stages of health planning. However, one significant shortfall 
is that these methods fail to also consider the socially constructed relations between men and 
women, instead focusing solely on the gaps in women’s health.  
 
In contrast, a gender equality approach is centrally concerned with power relations and considers 
that health may also be a site of gender conflict. It considers the role of gender relations in the 
production of vulnerability to ill health or disadvantage within health care systems and the 
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conditions which promote inequality between the sexes in relation to access and utilization of 
services (Sen and Östlin, 2009). This allows a far broader analysis that associates women’s 
vulnerability to ill health with their lack of power and control in all areas of their life (WHO2).  
 
Understanding gender in the context of global health policy and funding 
The challenges of policy framing and instrumentalism in women’s health  
Priority setting in global health policy is a highly politicized process and is not simply established 
through evaluations of burden or distribution of disease (Parkhurst and Vulimiri 2013: 1094). 
This is particularly evident around women’s health issues and advocates have reflected on the 
challenges of placing ‘women’s issues’ such as cervical cancer or maternal health on the global 
policy agenda (Starrs 2006; Shiffman and Smith 2007; Storeng and Béhague, 2014; Parkhurst and 
Vulimiri 2013).  
 
Consequently women’s health issues are frequently translated into easy-to-understand targets that 
fit within a wider instrumentalist agenda - as is evident in the integration of maternal mortality 
into the MDG agenda. However, this fails to take into account the wider health systems, yet a 
major element of health system strengthening is ensuring accountability to all citizens (Freedman 
et al., 2005). Moreover, the separation of activities around treatment and prevention of infectious 
diseases such as HIV AIDS, undermine overall health systems approaches to tackling their 
spread (Hanefeld 2010; Kapilashrami and McPake 2013). 
 
Critical analyses of the shortcomings of the MDG framework also provide valuable lessons for 
work on PPPs. The narrow focus within the MDGs has diverted attention away from the wider 
                                                 
2 http://www.who.int/gender/mainstreaming/strategy/en/index.html, accessed 30/10/13. 
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goals of social justice; this is particularly evident in efforts to meet the MDG target 5, especially 
the reduction of maternal mortality rates (Freedman 2005; Fukuda-Parr 2012; Storeng and 
Béhague, 2014; Yamin and Boulanger 2013). Similar concerns have been raised in relation to 
PPPs, as Birn (2014: 26) warns ‘there is no PPP for social justice in health’. At the level of policy 
and practice, instrumental understandings of women’s health can reinforce the narrowing of 
interventions to those that fit within the goal-based model of development (Esser and Bench 
2011; Porter and Wallace 2013). Moreover, evidence has shown that interventions that promote 
women’s participation in meaningful ways and recognise women’s knowledge are more likely to 
bring about effective reductions of maternal mortality rates (Lo, 2008; Prost et al. 2013). Indeed, 
health systems themselves are gendered institutions and frequently constrain women’s access to 
services (Mackintosh and Tibandebage 2006; Gideon, 2014).  
 
 
Negotiating ideas of gender in the context of global health PPPs  
Considerable discussion has been generated by the growing role of PPPs in global health. Here 
particular focus will be given to the implications of PPPs for gender and health, and within that 
how ‘women’s health’  reflects the narrow and goal-based understandings that could be defined 
as a ‘gender equity’ approach, rather than the more broad-based, socially determined 
understandings of women’s health represented by a ‘gender equality’ approach. While very little 
work has focused on the gendered implications of PPPs, critics have noted the absence or 
limited engagement with gender issues within central policy documents pertaining to a number 
of PPPs. Hawkes and Buse (2013) found that a number of organizations – including the 
GFATM and the UK Department for International Development [DFID] - still advocated an 
‘add women and stir’ i.e. a gender equity approach to health policy. Similarly an analysis of PPPs 
in SRH found that despite aspirations to ensure more efficiency and more equity via PPPs, in 
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many contexts these were based on assumptions that were not justified by the empirical evidence 
(Ravindran and Weller, 2005).  
 
The MDG agenda clearly placed women’s reproductive health on the global development agenda 
and it is therefore not surprising that the Gates Foundation committed to funding work around 
reproductive health, notably family planning. Indeed as the Foundation announces on its 
website:  
 
Family planning is a key part of the foundation’s broader commitment to 
empowering women and improving family health 
(http://www.gatesfoundation.org/What-We-Do/Global-Development/Family-
Planning). 
 
The Gates Foundation is currently a central player in the global health field, with a budget equal 
to that of the WHO in 2007 (McCoy et al. 2009). Gates has been active in a number of PPPs—
notably in the Global Alliance for Vaccines and Immunisation (GAVI), the GFATM, and 
specifically in funding innovative research work to develop an HIV vaccine. In 2012 the Gates 
Foundation Family Planning initiative was set up which is a collaborative undertaking between 
the Gates Foundation, other private foundations, governments and bi- and multi-lateral funding 
bodies, NGOs and the private sector. The need that has been identified is for women to have 
access to safe, affordable and effective contraception. The justification for the initiative is, 
however, primarily economic:  
 
Access to voluntary family planning has transformational benefits for women and 
girls and is one of the most cost-effective investments a country can make in its 
future. It is estimated that every US$1 spent on family planning can save up to $6 on 
health, housing, water, and other public services.  
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Access to contraceptives also leads to:  
 Fewer deaths among women and newborn babies and wider health benefits;  
 More girls completing their education and greater opportunities for girls;  
 Healthier and more prosperous families and communities;  
 Reduced demands on social sector budgets (Family Planning 2020)3. 
 
The Gates Foundation clearly draws on the more limited understanding of gender equity rather 
than gender equality approach and also perpetuates the instrumentalist analysis in its underlying 
justification for the focus on women’s health. It is, then, important to understand how these new 
partnerships in global health formulate a very specific and limited understanding of women’s 
health needs, and also then governs how the initiatives to respond to them are conceptualized. 
 
Given the variable nature of PPPs it is hard to generalise about their operation on the ground 
but a number of studies do offer some insights. Within the field of maternal health PPPs have 
focused on a number of different initiatives but the majority are primarily oriented towards 
improving access to affordable services, particularly for poor women (Ravindran, 2011). One 
strategy that has proved popular is the implementation of performance-based financing schemes 
such as that funded by GAVI in Cambodia. Here health centres are reimbursed for antenatal 
care visits and immunisation doses (Matksuoka et al., 2014).  Another widespread initiative 
funded through PPPs is the use of voucher-like schemes such as that found in Gujarat state in 
India. Here the Scheme for Long Life provides free institutional delivery care to poor women by 
contracting out delivery services to private obstetricians (Jehan et al., 2012: 146). While the long 
term impact of many of these types of schemes is not yet clear due to a lack of evidence, several 
critics have argued that questions of equity are still not being sufficiently addressed through such 
                                                 
3Family Planning 2020, p.4 
http://www.familyplanning2020.org/images/content/documents/About_the_London_Summit_on_FP_-
_Summary_Document.pdf 
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projects and the issue of accessibility and quality of care remains an on-going challenge 
(Matksuoka et al., 2014:; Jehan et al., 2012; Kanya et al., 2014; Ravindran, 2011). 
 
 
Concern has been expressed over the implications of PPPs for health inequalities given that the 
majority of PPPs do shift the focus away from broader approaches to health, focusing instead on 
disease-specific problems (Pitt et al. 2010). Indeed, Koivusalo and Mackintosh (2011) argue that  
 
The intervention of non-state (private sector) actors in health sector has also 
influenced global/ national agenda setting in health sector and emphasized a shift 
away from a broader approach that encompasses the social determinants of health 
and towards more disease-specific and disease-based which can lead to inequalities on 
the basis of diagnosis ... it can also draw resources away from, rather than contribute to, 
the overall health system, and can fragment health system institutions and health 
policy action (2011: 249).  
 
Several mechanisms have been put in place to try to avoid these tensions and to ensure that 
disease-specific initiatives are consistent with health sector strengthening efforts (Storeng, 2014). 
Nevertheless, ‘vertical-horizontal tensions persist, even in these more carefully designed efforts’ 
(Shiffman 2006: 418). Furthermore, empirical studies show that there is little evidence of donor 
priorities reflecting country level need or priorities (Esser and Bench 2011; Greco et al. 2008 
Paul et al. 2013). Research on official development assistance (ODA) in the area of reproductive 
health found that global health initiatives and disease-specific funding channels play an important 
role in the financing of reproductive health. Moreover, several studies point to the way in which 
funding for HIV work has come to dominate reproductive health work across a variety of 
country settings (Hsu et al., 2013; Shiffman et al., 2009).  
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Indeed, the preference for technical interventions that results in improvements in measurable 
indicators (such as birth-rates), but also creates new markets for health products, can mean that 
PPP interventions shift the balance between available contraceptive methods. In effect this can 
create a larger proportion of prescription of methods such as oral and injectable methods, that 
require screening and follow up care for possible side effects which are rarely available through 
PPPs, suggesting that ‘commercial interests and profit motives may in fact lead the agent to 
underplay the risks of the method’ (Ravindran and Weller,  2005: 122). Moreover, results-based 
health care is often the guiding principles of PPPs – an approach which privileges quantitative 
methods but fail to take into account the broader dimensions of health, and particularly how 
gender inequality and women’s subjugation affect their health needs, and their access to health 
services (Hanefield et al. 2007). 
 
Power relations between PPP ‘partners’ 
Another concern around PPPs is the quality of the partnerships themselves, particularly where 
global donor partners frequently impose their agendas on recipient countries (Koivusalo and 
Mackintosh 2011). This can result in local level organizations having to amend their practice in 
order to secure funding even where this may go against the fundamental principles of the 
organization (Ghanotakis et al. 2009). Commentators have also expressed concern about the 
impact of contracting on national-level NGOs and civil society organizations (CSOs) to carry out 
advocacy work (Spicer et al., 2011; Zaidi et al., 2012). This raises important questions and 
challenges for the ability of women’s rights advocates to challenge the dominant model of 
women’s health and have any meaningful voice in policy processes. 
 
Philanthropic organisations  
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At the global level, private philanthropic foundations have played a large role in the emergence 
and acceptance of PPPs, with the Gates Foundation ‘instrumental in the formation of public-
private partnerships involving the WHO’ (Ravindran and Weller 2005: 97). The important role 
played by the Gates Foundation is reinforced by the very large amounts of contributions, which 
dwarfed any other single contribution. While this high level of resources sets philanthropic 
organisations apart from other actors and provides them with the ‘risk tolerance’ to undergo 
projects that require many years of interventions, concerns have been raised around their 
legitimacy (Birn, 2014; Moran and Stevenson, 2013).  
 
In contrast to organisations such as NGOs that are able to claim a bounded form of legitimacy 
derived from direct association with their members and supporters, or loose links with social 
movements or grassroots organisations, philanthropic foundations lack this ‘democratic’ 
dimension (Moran and Stevenson, 2013). At the same time, while they operate in an atypical 
space, distinct from but closely associated with market actors such as firms, they also retain 
unusually strong links with the private sector for example familial connections through trustees 
who remain active in the corporate world (2013: 136). For many foundations, measurability is 
also a key factor in determining where the money goes because it facilitates resource mobilization 
as well as the production of easily attributable success stories (Esser and Bench 2011).  
 
NGO partnerships 
Questions around the balance of power between partners within PPPs have been raised within 
the broader literature (Farah and Rizvi, 2007; Hawkes and Buse, 2011). When NGOs engage 
with private sector partners, the partnership can involve many different roles. These partnerships 
can include working with donor funds to implement activities, working with accountancy and/or  
consultancy firms  who manage consortia projects since they are often seen as having a 
comparative advantage over NGOs because of their ability to present a ‘business case’ for 
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development work and consortia partners. Partners in NGO work can therefore include large 
accountancy and consultancy firms, international commercial banks, global insurance companies 
and other global corporate enterprises. Some NGO workers argue that these developments have 
led to a shift from private sector partners ‘raising profile’ through involvement in development 
work, to a more accepted notion that development work should harmonise with business 
objectives to generate markets and profit (DSA Study Group report, 2015). Some NGO workers 
identify positive elements to the relationship with corporate partners, such as spreading the risk 
of new, innovative, projects, and increased expertise in areas such as monitoring and evaluation, 
as well as the opportunity to influence corporate partners positively on gender issues. However, 
there are also more negative consequences, including an often-felt preference for quantitative 
rather than qualitative data, a reluctance to invest in more intractable problems with harder-to-
reach communities, and a lack of (downwards) accountability to NGO partners and 
communities.    
 
Changing narratives of gender and health in UK-based NGOs 
The growth and acceptance of particular market-oriented norms and principles within the health 
sector has been documented in a number of studies (Birn, 2014; Storeng, 2014; Storeng and 
Béhauge, 2014; Ravindran and Weller, 2005). The role of the private sector in the health sector 
has brought about shifts in how healthcare, and within that women’s health, can be understood 
and addressed. Nevertheless, there is a gap in understanding how NGOs have responded to this 
shift at the level of practice. Focusing on the local level impact of the Global Fund in India 
Kapilashrami and McPake (2013) emphasise the ‘hidden transcripts’ of power and the creation of 
a competitive environment in which projects struggle for funding. Although their study did not 
specifically focus on the gendered implications, the effects are such that the voices and work of 
local organizations are excluded.  
 12 
 
NGOs are dependent on external funding, and echoing the ‘hidden transcripts of power’, this 
dependence shapes how they frame the work that they undertake, and how they are able to 
report on this work. Authors such as Mosse (2005) have documented how development NGOs 
will create a ‘narrative’ of their work, reflecting the changing context in which they are being 
evaluated, and seeking funding.  
 
Projects do not ‘work’ because they turn policy into reality, but because they sustain 
policy models offering a significant interpretation of events (which is not the same as 
operational control over events or practices) (Mosse 2005: 17). 
 
This has created huge tensions in development NGOs, where the pressure is felt to create a 
‘narrative’ of development work that corresponds with donor requirements. These donor 
requirements are increasingly based on tightly controlled, efficient processes that can 
demonstrate ‘value for money’ (Porter and Wallace 2013). The research conducted for this paper 
has indicated that UK-based NGOs are  increasingly reliant on institutional funding from bi- and 
multi-laterals, and also from PPPs or direct corporate partnerships.  
 
Overall, amongst the NGOs participating in this research, the proportion of funding from the 
private sector is not more than a small percentage of the total funds. The vast majority of NGO 
funds still come from institutional funders such as DFID and the EU. Sometimes institutional 
funding is through programme partnership agreements (PPAs), which is highly valuable because 
it is unrestricted funding, but more often these funds are restricted and have high cost 
implications because of the level of monitoring and evaluation that is required to ‘service’ them 
(BOND, 2015).  
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However, the potential offered to NGOs via PPP funding is significant. This is evident in a 
recent DFID health investment programme - ‘Harnessing Non-State Actors for Better Health 
for the Poor’ (HANSHEP), which has a budget of just under £35 million over eight years (2010-
2018). The HANSHEP website states its mission as  improving ‘the performance of the non-
state sector in delivering better healthcare to the poor by working together, learning from each 
other, and sharing this learning with others’ (http://www.hanshep.org/about-us/our-mission4). 
Moreover, its objectives include ensuring that ‘an increased number of poor people, in particular 
women and children will receive better quality and more affordable, or free, health services...’ 
(http://devtracker.dfid.gov.uk/projects/GB-1-201101/5). Thus whilst direct funding from 
individual private sector partners is still a relatively small proportion of NGO funds, the potential 
to grow this funding was seen to be significant by most of the organisations participating in this 
research.  
 
The ongoing shift in funding regimes for health programmes has profoundly affected NGO 
narratives around their work in this area. Organizations need to prove their ability to address the 
priority areas of the donors, and produce work that can be measured to show successful 
implementation (DSA Workshop report, 2005; Esser and Bench 2011; UKNGO1). NGOs are 
thus becoming active proponents of PPPs, and find that their work is now being shaped in 
specific ways to ‘fit’ the current development discourse (UKNGO 1, 8, 10). Similar findings have 
been reported elsewhere (Birn, 2014; Storeng, 2014).  
 
This shift in the focus of the funding regimes has brought about many positive changes in the 
operational work of NGOs, not least by increasing the amount of funding available. However, 
this shift also has the potential to undermine the effectiveness of interventions in bringing about 
                                                 
4 Accessed 5/6/15 
5 Accessed 5/6/15 
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greater gender equality. This paper has shown how the differences between gender equality and 
gender equity approaches can have differential impacts on the outcomes of women’s health 
interventions. Whilst instrumental gains in gender equity will often result in undeniably positive 
gains for women’s health, they will not necessarily lead to desired outcomes in women’s 
empowerment and the broader social determinants that govern how women experience health 
and health care. In order to investigate how to close the gap between these two approaches there 
is a need for more detailed empirical studies which reveal the local level impact of the global 
health agenda and give particular attention to gendered power relations. As a step towards filling 
this knowledge gap the following section of the paper draws on an analysis of UK-based NGOs 
to examine how health policy and programming reflects the changing landscape of funding 
patterns. Specific attention is given to ability of NGOs to understand and incorporate an analysis 
of gender equality in their current work on women’s health issues. 
 
The case study: women’s health within UK-based NGOs 
The research questions governing this study were: how and to what extent these underlying ideas 
around women’s health had reached UK-based NGOs, and were affecting their understanding 
of, and ability to address, women’s health needs. As the study investigated the construction of 
knowledge and understanding, it was important to draw on qualitative research methodologies, 
and be able to respond to the data as it emerged. Semi-structured interviewing techniques were 
used, identifying a range of respondents from UK-based NGOs and women’s health networks, 
sampling both independently and progressively as the process continued (Bryman, 2008). By 
identifying as wide a range of respondents as possible within UK-based NGOs, the study has 
avoided narrow definitions of NGOs and their work, and concentrated rather on how each one 
(located differently, and with different styles/methods of working on health) was affected by the 
 15 
influence of PPPs in their work on women’s health. The sample can be understood as a broad 
case study approach, rather than a specific in-depth case study of a particular organisation (Yin, 
1994).  
 
Interviews were conducted over a 15 month period with 20 respondents - 13 from 7 different 
UK-based NGOs, 5 respondents from transnational women’s health networks, and 2 global 
health governance experts. All respondents worked on health issues with some particularly 
concerned with women’s health or gender equality in health, and others more generally with the 
governance and funding of health in development.  
 
NGOs are far from a homogeneous group of organisations. In the context of the UK, NGOs 
range from small local service-delivery organisations through to large primarily advocacy-based 
NGOs and funding organisations working internationally. This analysis is not concerned to pin-
point the individual differences between these organisations; rather it seeks to formulate an 
understanding of their changing relationship with the dominant underlying ideologies of the 
global health system, and particularly the role of PPPs within that, and how this has affected 
their fundraising, programming, and monitoring and evaluation. What all the NGOs studied 
have in common is that they are dependent on funding from external sources. This research 
concentrated on the relationship between funding patterns and the consequences of shifting 
patterns for the understanding of women’s health. For the respondents, funding was often from 
DFID, but many organisations also sought funding from private foundations or directly from 
corporate organisations.  
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Policy framing: women’s health in NGO programmes and the need for resources 
NGO respondents recognized that women’s health is primarily seen in terms of technical 
interventions to address reproductive and maternal/child health and that this is a deliberate 
strategy to secure funding. Whilst on an individual basis some respondents had broader 
understandings of women’s health, the NGOs they represented had historically been associated 
with narrower conceptualizations of women’s health, which were often used to frame and plan 
interventions targeted at service-delivery (UKNGO10, UKNGO11). This meant that many 
NGOs found it relatively uncomplicated to negotiate funding relationships based on this 
approach. While one respondent commented that the women and girls agenda in global health 
does ‘not necessarily reflect all we know about gender inequality’ (UKNGO5), she clearly 
accepted the need to respond to the agenda as it is currently constructed, which concentrates on 
single-issue, technical interventions targeted at reproductive health needs, such as family 
planning, and maternal and child health. 
 
All the respondents acknowledged the current changes in the funding landscape related to the 
increased participation of private sector and corporate partners, often in global PPPs, which 
many attributed to the current climate of austerity, in which individual donations are falling 
[UKNGO7, UKNGO10]. Most respondents understood the opportunities to gain increased 
funding via PPP-led funding, and saw these new opportunities to address the healthcare needs of 
women and girls, however narrowly these are conceptualized [FONGO1, UKNGO10, 
UKNGO7, UKNGO8, FONGO2, UKNGO5]. They saw their work focused on women and 
girls in global health as on-going, and negotiated within a broader set of priorities that are often 
shaped by donors. However, the opportunity to pursue funding through further corporate 
partnerships, whether directly or via a PPP, frequently undermined how far they were able to 
integrate a more complex gender analysis of women’s health. 
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While one NGO focused much of its international advocacy work at the level of the WHO, 
lobbying for universal coverage for healthcare this was not associated with ‘women’s health’. 
‘Women’s health’ is defined differently because it is funded from different sources, and is limited 
to reproductive and maternal/child health (MCH). There was no clear gender analysis of health 
systems or broader understandings of women’s health within their advocacy work to support 
universal coverage for healthcare systems (UKNGO10). This reflects the difficulties that NGOs 
have in incorporating a broader understanding of gender equality in health, which requires an 
attention to gender inequalities not just in reproductive and MCH programmes, but also in work 
to address how health systems themselves reflect and perpetuate gender inequality. Despite 
widespread empirical evidence that has shown how gender inequalities can constrain women’s 
access to health services these analytical approaches rarely translate into the work of NGOs 
working to advocate for universal coverage for healthcare. Women’s health remains defined 
within the narrow confines of reproductive health and MCH programmes. 
 
Clearly funding is a crucial determinant in how work on women’s health is conceptualized and 
implemented through programming, and funding patterns have changed significantly since PPPs 
have become such an accepted part of the development funding landscape. Respondents 
recognized that the requirement for results-based management and ‘value for money’ is currently 
a high priority, including for both PPP-led funders and bi-lateral funders such as DFID, and that 
this impacts on how far they are able to integrate boarder understandings of women’s health. 
When asked about how these funding frameworks affect their health work, respondents 
confirmed that when managed within these frameworks, there is far more emphasis put on 
developing and meeting robust indicators (which are often quantitative) to secure further 
funding [UKNGO1, TNN1, FONGO1, FONGO2]. For example, there has been an increase in 
interest in the use of Randomized Controlled Trials to measure the impact of health programmes 
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in development (Welbourn 2013). Some respondents saw these as an opportunity to give 
credibility to women’s health programmes, and were keen to find ways to use these methods 
more in the evaluation of women’s health programmes. Others feared that an over-reliance on 
methods such as these would continue to shape the understanding of women’s reproductive 
health around quantitative indicators, rather than more complex analyses of power and inequality 
[TNN2]. Another clear shift in funding patterns was the increased interest from private 
foundations and corporates in forming direct partnerships with NGOs. Whilst all funding 
opportunities are welcomed by NGOs, the consequence for many staff is that they spend much 
more time on preparing proposals, and pursuing fund-raising opportunities [FONGO1]. This 
has a negative effect on the quality of programmes as they are designed to respond to donor 
agendas, rather than needs articulated by partners. 
 
The impact of PPPs on the negotiation of gender issues in NGO health programming  
The impact of PPPs in shaping NGO programmes can be seen more broadly, showing that the 
influence of donor priorities goes beyond the immediate need for resources to fund specific 
programmes. A number of the respondents (UKNGO2, UKNGO3, UKNGO10, TNN5, 
TNN3, UKNGO7) commented on the influence of private foundations, the Gates Foundation 
in particular, and at least one major NGO made clear that the stated agenda of the Gates 
Foundation influenced how their own programmes would be shaped (for example developing 
new project work to reflect the Gates interest in vaccinations - UKNGO10). The role of the 
Gates Foundation was welcomed by most NGO respondents given the increase in funding and 
greater profile of women’s health within the development contexts. However, this profile is 
generally limited to technical interventions targeting immediate reproductive health and MCH 
needs.  
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The influence of the Gates Foundation was not limited to the possibility of financial support. 
The pervasive influence of Bill Gates in the health field was widely acknowledged by 
respondents [UKNGO2, 3, 4, 7, 8, 10, GHG2]. Storeng and Béhague (2014) argue that the 
‘Gates approach’ has encouraged the international maternal health community to focus on 
‘magic bullets’ such as antibiotics to prevent maternal deaths. Similarly this study points to an 
embedding of a limited discourse of women’s health within the narrative of NGO programming. 
The ‘Gates approach’ has particular implications for the discourse of women’s health because of 
the focus on women’s reproductive health via family planning initiatives. Respondents were 
divided on the potential of the ‘Golden Moment’ initiative for improving women’s health. Those 
within NGOs saw an opportunity to raise the profile of women’s reproductive health and rights 
and achieve ‘real’ gains in terms of numbers of women accessing family planning [UKNGO10]. 
Moreover, the participation  of Melinda Gates was seen as having a positive impact it terms of 
expanding discourse and including the idea of rights alongside reproductive health [TNN3] after 
the restrictions placed on language around sexual and reproductive rights given the ideologically 
and politically constrained position of the US government6. However, respondents involved in 
lobbying around the 2012 London Summit identified a risk that in concentrating resources on 
access to contraception, other aspects of women’s reproductive health (such as women’s ability 
to negotiate sexual relationships in a context in which violence against women is accepted and 
endemic) may become even further neglected (GADN 2012). Thus, whilst acknowledging some 
gains in terms of measures to meet development goals such as reducing maternal mortality, there 
are limitations to such an approach. Even where health programmes can be shown to have 
contributed towards a reduction in maternal mortality, data targeted at this kind of simple goal 
does not capture the broader constraints faced by women in accessing healthcare (Petchesky 
2003; Yamin and Boulanger, 2013; Yamin and Falb, 2012). These broader understandings of 
                                                 
6 Mayhew (2002) documents the way that the US government’s conservative position on sexuality negatively 
affected how organizations involved in HIV/AIDS in sub-Saharan Africa were able to respond to the needs of the 
community for sexual and reproductive health services and advocacy.  
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women’s health (for example, mortality as a result of unsafe abortion) can in fact undermine the 
apparent gains of the more instrumentalist ideas (Yamin and Boulanger 2013). The ‘Gates 
approach’ is increasingly seen in other PPPs, such as DFID’s HANSHEP initiative.  
 
Negotiating NGO relationships with private sector partners at the local level 
Within the context of global PPPs civil society organizations have often been viewed as agents of 
service delivery rather than as agents of change (Spicer et al. 2011; Harmer et al. 2012). Indeed 
Spicer et al. (2011) found that in the former Soviet Union, where NGOs were invited to play a 
role in high level partnerships they ultimately lost their connection with the social movements 
from which they had initially evolved. Similarly, Harmer et al. (2012) found that the pressure for 
securing resources from the PPPs led to competition between civil society organizations and 
limited any real potential for advocacy work. Similarly this research found that many NGOs had 
only a limited space to engage in advocacy and push for a broader understanding of women’s 
health in their work. Instead they were frequently limited to refining their role in health service 
delivery. 
 
Research respondents recognized that partnerships are often a way in which corporate 
organizations can improve their own credibility through their association with the NGO 
[UKNGO7, 8]. This might give the NGO partner some power to assert their own knowledge 
and experience of local realities. However, most respondents saw the corporate partnerships as 
an opportunity to learn about improving efficiencies and designing effective implementation and 
distribution mechanisms [UKNGO10]. So although such NGO-corporate partnerships could 
enable a more fundamental sharing of ideas and expertise between NGOs and corporate 
organizations, the shared ideas appear to privilege the market-led needs of distributing products 
or services, rather than utilizing the knowledge and experience of NGOs derived from broad-
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based work around women’s empowerment. As one respondent reflected, this type of 
knowledge can be much more complex and more difficult to encapsulate within simplistic goal-
based models (FONGO2). It appeared from the study that although NGOs had significant 
power, based on the value of their ‘brand’, they did not want to use this power to fundamentally 
challenge their new partners on, for example, the need to address the broader social and political 
determinants of women’s health. 
 
Reflecting the work of Ravindran and Weller (2005) our analysis found that NGO respondents 
(FONGO2, UKNGO8) have, in many cases, accepted private sector involvement, and 
expertise—for example through designing and running service-delivery initiatives that can be 
easily measured and ‘success’ proved. Some (FONGO2, UKNGO7) expressed the tensions that 
this causes within the organization, as other people feel that their own expertise and their 
alignment perhaps with other categories of actors (such as transnational advocacy networks) are 
being undermined. Indeed, this reinforces the findings in other studies, for example in relation to 
work around HIV/AIDS in the context of the Global Fund. Cáceres et al. (2013) found that 
broader knowledge around HIV/AIDS prevention can become lost in practice where the 
medical components of models are prioritized over and above other more participative 
approaches involving a wider range of stakeholders. 
 
However, other corporate-NGO partnerships are negotiated and take place at the local level, and 
are managed by the country offices of the different NGOs. This can provide the opportunity for 
the organization to respond differently. In one case it was not so much the ideas of women’s 
health that were compromised, but more the ideas of development interventions being free of 
market-oriented involvement. The corporate partner was not necessarily looking for improved 
measurable health outcomes, thus providing more flexibility and enabling resources to be 
focused on a more complex programme addressing gender inequality in health. However, the 
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NGO had to accept the corporate partner’s priority as well: access to markets. There are many 
different ways in which the private sector can play a role in the health sector (Ravindran and 
Weller 2005), and this is another illustration of how PPPs can shift the understandings and 
practice of work around gender equality.  
 
In sum, our analysis found that there has been a widespread impact of PPPs, and their influence 
both on funding regimes and more broadly in constructing a narrative of women’s health in 
development, whether or not the NGOs are directly in partnership with PPPs. Whilst the 
influence of PPPs has been to increase the funding available, the role of NGOs within these 
partnerships is frequently reduced to one of service delivery. In effect the role of NGOs in 
advocating for women’s health is marginalized, thus reinforcing narrow understandings of 
women’s health—as reproductive and maternal/child health in practice. Furthermore, although 
the influence of PPPs has led to an emphasis on efficiency and effectiveness, which has been 
welcomed by many in NGOs, it has also changed how interventions are designed and managed, 
focusing much more on showing value for money through quantifiable indicators of impact, 
than on showing more qualitative shifts in how women experience health and health care. While 
partnerships can clearly differ in quality, the way that the agenda has shifted away from an 
understanding of gender inequality in health remains of concern to many respondents (TNN1, 
TNN4, TNN5).  
Conclusion 
It is clear that in the context of global health, a significant shift is occurring in both funding 
patterns and the management of health care in development policy and practice. Power and 
influence has not only shifted away from the state and inter-governmental structures of 
governance towards the global structures of the UN, WB, and WHO, but it has also been 
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changed by the increased participation of non-state actors, notably from large private sector 
organizations, operating within ‘PPPs’ at the level of global health governance.  
 
The shift in the funding architecture of global health has had a profound impact on how the 
health of women is understood in development policy and practice. Despite a wealth of 
knowledge and analysis of gender equality in health, it is clear that the influences emerging from 
some of the private foundations and private sector actors are reducing the understanding of 
women’s health to more instrumentalized notions of maternal and reproductive health. Whilst in 
some cases this may have led to a reduction in particular indicators such as maternal mortality, it 
does restrict how women’s health is understood, separating it from broader and more complex 
ideas that govern how women (particularly poor and marginalized women) are able to access 
health care throughout their lives. Health systems must be understood as social institutions, and 
women’s ability to access health systems will be based not only on the rather abstracted notions 
of women’s rights to health contained within UN documents, but also on how women’s 
empowerment and citizenship can be negotiated in each context.  
 
Furthermore, gender equality in health is significantly undermined by the models of healthcare 
that are promoted by PPPs, which promote goal-based and predictable models, with easily 
quantifiable outcomes and indicators with which to measure them. Although the effect of these 
influences has been relatively well documented at the global level there is still very little 
understanding of the impact that these influences have at other levels in development policy and 
practice. This research has begun to trace this influence from the increased participation of PPPs 
at the global level, to their impact in development policy and practice at the national and local 
level.  
 
Respondents:  
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NGO respondents based in the UK (UKNGO1 – UKNGO11) 
NGO respondents based in field offices (FONGO1 – FONGO2) 
Trans-national network respondents (TNN1 – TNN5) 
Global Health Governance experts (GHG1-GHG2) 
References 
Birn, A-E. (2014) ‘Philanthrocapitalism past and present: the Rockefeller Foundation, the Gates 
Foundation and the setting(s) of the international/global health agenda’, Hypothesis, 12 (1): 
1-27, e6, doi:10.5779/hypothesis. v10i1.229. 
BOND (2015) ‘Fast forward: the changing role of UK based INGOs’ available at 
http://www.bond.org.uk/data/files/reports/Fast_Forward_0515.pdf, (accessed 5/6/15). 
Bryman, A. (2008)Social Research Methods (3rd Edition), Oxford University Press: Oxford. 
Buse, K. and A. Harmer (2007). ‘Seven Habits of Highly Effective Global Public–Private Health 
Partnerships: Practice and Potential’. Social Science & Medicine, 64: 259-71. 
Buse, K. and S. Tanaka (2011). ‘Global Public-Private Health Partnerships: Lessons Learned 
from Ten Years of Experience and Evaluation’. International Dental Journal, 61 (Suppl. 2): 2-
10, doi: 10.1111/j.1875-595X.2011.00034.x. 
Buse, K. and G. Walt (2000). ‘Global Public-Private Partnerships: Part II – What are the Health 
Issues for Global Governance?’. Bulletin of World Health Organisation, 78(5): 699-709. 
Buse, K., N. Drager, W. Hein, B. Dal, and K. Lee (2009). ‘Global Health Governance: The 
Emerging Agenda’. In K. Buse, W. Hein, and N. Drager (eds), Making Sense of Global Health 
Governance. Palgrave Macmillan: Basingstoke and New York.  
 25 
Cáceres, C., A. Amaya, C. Sandoval, and R. Valverde (2013). ‘A Critical Analysis of Peru’s HIV 
Grant Proposals to the Global Fund’. Global Public Health: An International Journal for Research, 
Policy and Practice, 8(10): 1123-37, doi: 10.1080/17441692.2013.861859. 
Development Studies Association (DSA) Study Group on Gender Policy and Practice (2015) Is 
there still space for gender equality in the current gender narratives of development?, Report of Study 
group meeting, Holloway Resource Centre, London, 27th January 2015, 
http://www.devstud.org.uk/studygroups/gender_and_practice_study_group-33.html, 
(accessed 20th May 2015).  
Esser, D. and K. Bench (2011). ‘Does Global Health Funding Respond to Recipients’ Needs? 
Comparing Public and Private Donors’ Allocations’. World Development, 39(8): 1271-80. 
Farah, Iffat and Sadaf Rizvi (2007) ‘Public-private partnerships: implications for primary 
schooling in Pakistan’, Social Policy Administration, 41 ( 4): 339-354. 
Freedman, L. (2005). ‘Achieving the MDGs: Health Systems as Core Social Institutions’. 
Development, suppl. The Millennium Development Goals, 48(1): 19-24. 
Freedman, L.P., R.J. Waldman, H. de Pinho, M.E. Wirth, A. Mushtaque, R. Chowdhury, and A. 
Rosenfield (2005). ‘Transforming Health Systems to Improve the Lives of Women and 
Children’. Lancet, 365: 997-1000. 
Fukuda-Parr, S. (2012). ‘Should Global Goal Setting Continue, and How, in the Post-2015 Era?’. 
DESA Working Paper No. 117, ST/ESA/2012/DWP/117, 
http://www.un.org/esa/desa/papers/2012/wp117_2012.pdf, accessed 30/10/13.  
Gender and Development Network (GADN) (2012). ‘DFID’s Golden Moment Initiative on 
Family Planning: A Gender and Development Network Response’. Briefing No. 1, 
http://www.gadnetwork.org.uk/storage/GADN%20Briefing%201%20-
%20DFID’s%20Family%20Planning%20Summit.pdf, accessed 26 March 2013.  
 26 
Ghanotakis, E., S. Mayhew, and C. Watts (2009). ‘Tackling HIV and Gender-based Violence in 
South Africa: How has PEPFAR Responded and What are the Implications for 
Implementing Organizations?’. Health Policy and Planning, 24: 357-66. 
Gideon, J. (2014). Gender, Globalisation and Health in a Latin American Context. Palgrave Macmillan: 
New York and Hampshire. 
Greco, G., Powell-Jackson, T., Borghi, J and Mills, A. (2008) ‘Countdown to 2015: assessment of 
donor assistance to maternal, newborn, and child health between 2003 and 2006’, Lancet, 
371: 1268–75 
Hanefeld, J. (2010). ‘The Impact of Global Health Initiatives at National and Sub-national Level 
a Policy Analysis of their Role in Implementation Processes of Antiretroviral Treatment 
(ART) Roll-out in Zambia and South Africa’. AIDSCare, 22 supp 1, 93-102. 
Hanefeld, J., N. Spicer, R. Brugha, and G. Walt (2007). ‘How Have Global Health Initiatives 
Impacted on Health Equity?’ A Literature Review Commissioned by the Health Systems 
Knowledge Network, http://www.who.int/social_determinants/resources/csdh_media 
/global_health_initiatives_2007_en.pdf (last accessed 31/1/12).  
Harmer, A., N. Spicer, J. Aleshkina, D. Bogdan, K. Chkhatarashvili, G. Murzalieva, N. 
Rukhadze, A. Samiev, and G. Walt (2012). ‘Has Global Fund Support for Civil Society 
Advocacy in the Former Soviet Union Established Meaningful Engagement or ‘A Lot of 
Jabber about Nothing’? Health Policy and Planning, 1-10, doi:10.1093/heapol/czs060. 
Hawkes S. and K. Buse (2013). ‘Gender and Global Health: Evidence, Policy and Inconvenient 
Truths’. The Lancet, 381: 1783-87. 
Hawkes, C. and K. Buse (2011) ‘Public health sector and food industry interaction: it’s time to 
clarify the term ‘partnership’ and be honest about underlying interests’, European Journal of 
Public Health, 21 (4): 400-403.  
 27 
Hsu, J., P. Berman, and A. Mills (2013). ‘Reproductive Health Priorities: Evidence from a 
Resource Tracking Analysis of Official Development Assistance in 2009 and 2010’. The 
Lancet, 381: 1772-82. 
Inhorn, M.C. (2006). ‘Defining Women’s Health: A Dozen Messages from more than 150 
Ethnographies’. Medical Anthropology Quarterly, 20(3): 345-78. 
Jehan, K., Sidney, K., Smith, H., and de Costa, A. (2012) Improving access to maternity services: 
an overview of cash transfer and voucher schemes in South Asia. Reproductive Health Matters, 20 
(39):   142-154. 
Kanya,L., Obare, F., Warren, C., Abuya,T., Askew, I.  and Bellows, B. (2014) Population Safe 
motherhood voucher programme coverage of health facility deliveries among poor women in 
South-western Uganda, Health Policy and Planning; 29:i4–i11 doi:10.1093/heapol/czt079 
Kapilashrami, A. and B. McPake (2013). ‘Transforming Governance or Reinforcing Hierarchies 
and Competition: Examining the Public and Hidden Transcripts of the Global Fund and 
HIV in India’. Health Policy and Planning, 28: 626-35. 
Koivusalo, M. and M. Mackintosh (2011). ‘Commercial Influence and Global Nongovernmental 
Public Action in Health and Pharmaceutical Policies’. International Journal of Health Services, 
41(3): 539-63. 
Lo, M. (2008) ‘Public-Private Partnerships for maternal health in Africa: challenges and 
prospects’, Marriage and Family Review, 44 (2-3): 214-237. 
Mackintosh, M. and P. Tibandebage (2006). ‘Gender and Health Sector Reform: Analytical 
Perspectives on African Experience’. In S. Razavi and S. Hassim (eds), Gender and Social 
Policy in a Global Context: Uncovering the Gendered Structure of ‘The Social’. Palgrave: Basingstoke. 
Matksuoka, S., Obara, H., Nagai, M., Murakami, H., and Lon, R. C. (2014) Performance based 
financing with GAVI health system strengthening funding in rural Cambodia: a brief 
assessment of the impact. Health Policy and Planning, 29 (4): 456-465. 
 28 
 
Mayhew, S. (2002). ‘Donor Dealings: The Impact of International Donor Aid on Sexual and 
Reproductive Health Services’. International Family Planning Perspectives, 28(4): 220-24. 
McCoy, D., Chand, S. and Sridhar, D. (2009) ‘Global health funding: how much, where it comes 
from and where it goes’, in Health Policy and Planning 24:407-417.  
Moran, M. and Stevenson, M. (2013) ‘Illumination and innovation: what philanthropic 
foundations bring to global health governance’, Global Society 27 (2): 117-137. 
Mosse, D (2005) Cultivating Development: An Ethnography of Aid Policy and Practice, Pluto Press, 
London and New York. 
Parkhurst, J.O. and M. Vulimiri (2013). ‘Cervical Cancer and the Global Health Agenda: Insights 
from Multiple Policy-analysis Frameworks’. Global Public Health: An International Journal for 
Research, Policy and Practice, 8(10): 1093-1108, doi:10.1080/17441692.2013.850524. 
Paul, E., M. Ireland, J. Martini, V. Zinnen, I. Ronse, S. Samaké, and B. Dujardin (2013). ‘Results 
from the Implementation of Aid Effectiveness Principles in the Health Sector in Mali’. 
Journal of Public Health Policy, 34: 140-52. doi:10.1057/jphp.2012.64; published online 29 
November 2012. 
Petchesky, R. (2003). Global Prescriptions: Gendering Health and Human Rights. Zed Press: London.  
Pitt, C., G. Greco, T. Powell-Jackson, and A. Mills (2010). ‘Countdown to 2015: Assessment of 
Official Development Assistance to Maternal, Newborn, and Child Health, 2003–08’. The 
Lancet, 376: 1485-96. 
Porter, F. and T. Wallace (2013). ‘Aid, NGOs and the Shrinking Space for Women: A Perfect 
Storm’. In T. Wallace and F. Porter, with R. Bowman (eds), Aid, NGOs and the Realities of 
Women’s Lives: A Perfect Storm. Practical Action, Rugby. 
 29 
Prost, A., T. Colbourn, N. Seward, K. Azad, A. Coomarasamy, A. Copas, T. Houweling, E. 
Fottrell, E. Kuddus, S. Lewycka, C. MacArthur, D. Manandhar, J. Morrison, C. 
Mwansambo, N. Nair, B. Nambiar, D. Osrin, C. Pagel, T. Phiri, A-M. Pulkki-Brännström, 
M. Rosato, J. Skordis-Worrall, N. Saville, N. Shah More, B. Shrestha, P. Tripathy, A. 
Wilson, and A. Costello (2013). ‘Women’s Groups Practising Participatory Learning and 
Action to Improve Maternal and Newborn Health in Low-resource Settings: A Systematic 
Review and Meta-analysis’. The Lancet, 381: 1736-46. 
Ravindran, T. K. S. (2012) Universal access: Making health systems work for women. BMC Public 
Health 12(Suppl 1): S4. http://www.biomedcentral.com/1471–2458/12/S1/S4. 
Ravindran, T.K. and S. Weller (2005). ‘Public-private Interactions in Health’. In T.K. Ravindran 
and H. de Pinho (eds), The Right Reforms? Health Sector Reforms and Sexual and Reproductive 
Health, http://www.wits.ac.za/academic/health/publichealth/genderhealth/rightsand 
reforms/10608/book:_the_right_reforms.html, accessed 30/10/13.  
Ruckert, A. and Labonté, R. (2014) ‘Public-private partnerships (ppps) in global health: the good, 
the bad and the ugly’, Third World Quarterly, 35 (9: 1598-1614.  
Sen, G. and P. Östlin (2009). Gender Equity in Health: The Shifting Frontiers of Evidence and Action. 
London and New York: Routledge.  
Shiffman, J. (2006). ‘Donor Funding Priorities for Communicable Disease Control in the 
Developing World’. Health Policy and Planning, 21(6): 411-20. 
Shiffman, J. and S. Smith (2007). ‘Generation of Political Priority for Global Health Initiatives: A 
Framework and Case Study of Maternal Mortality’. The Lancet, 370: 1370-79. 
Shiffman, J., D. Berlan, and T. Hafner (2009). ‘Has Aid for AIDS Raised All Health Funding 
Boats?’. Journal Acquired Immune Deficiency Syndrome, 52: S45-S48. 
 30 
Spicer, N., A. Harmer, J. Aleshkina, D. Bogdan, K. Chkhatarashvili, G. Murzalieva, N. 
Rukhadze, A. Samiev, and G. Walt (2011). ‘Circus Monkeys or Change Agents? Civil Society 
Advocacy for HIV/AIDS in Adverse Policy Environments’. Social Science & Medicine, 73: 
1748-55. 
Standing, H. (1997). ‘Gender and Equity in Health Sector Reform Programmes: A Review’. 
Health Policy and Planning, 12(1): 1-18. 
Starrs, A.M. (2006). ‘Safe Motherhood Initiative: 20 Years and Counting’. The Lancet, 368: 1130-
32. 
Storeng, K.T. (2014) ‘The GAVI Alliance and the “Gates Approach” to health system 
strengthening’, Global Public Health, 9 (8): 865-879. 
Storeng, K.T. and Béhague, D. (2014) ‘“Playing the numbers game”: evidence-based advocacy 
and the technocratic narrowing of the Safe Motherhood Initiative’ Medical Anthropology 
Quarterly, 28 (2):  260–279. 
Welbourn, A. (2013). ‘From Local to Global and Back Again – Learning from Stepping Stones’. 
In T. Wallace and F. Porter, with R. Bowman (eds), Aid, NGOs and the Realities of Women’s 
Lives: A Perfect Storm, Practical Action Publishing. 
Yamin, A.E. and V.M. Boulanger (2013). ‘From Transforming Power to Counting Numbers: 
The Evolution of Sexual and Reproductive Health and Rights in Development; and Where 
we Want to go from Here’. Working Paper Series, The Power of Numbers, a Critical Review of 
MDG Targets for Human Development and Human Rights, FXB Centre for Health and Human 
Rights, Harvard University, http://fxb.harvard.edu/working-paper-series, accessed 
30/10/13. 
 31 
Yamin, A.E. and K.L. Falb (2012). ‘Counting What We Know: Knowing what to Count: Sexual 
and Reproductive Rights, Maternal Health, and the Millennium Development Goals’. Nordic 
Journal on Human Rights, 30(3): 350-71. 
Yin, R.K. (1994) Case Study Research: Design and Methods (2nd Edition), Sage Publications: London 
Zaidi, S., S. Mayhew, J. Cleland, and A. Green (2012). ‘Context Matters in NGO–Government 
Contracting for Health Service Delivery: A Case Study from Pakistan’. Health Policy and 
Planning, 27: 570-81. 
 
